NCT00488189View on ClinicalTrials.gov

Study Evaluation Tazocin Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Bacterial Infections
Interventions
DRUG

Tazocin (pipercillin/tazobactam)

over 50% third generation cephalosporin should be replaced by Pip/Taz

Trial Locations (1)

100037

Beijing

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488189 - Study Evaluation Tazocin Intervention | Biotech Hunter | Biotech Hunter